Seed Co

Seed Co Debt/EBITDA

The Total Debt to EBITDA Ratio of Seed Co (7743.T) as of Oct 28, 2026 is 19.78. In the previous year, Total Debt to EBITDA Ratio was 16.81 — a change of 17.67% (higher).

Debt/EBITDA

19.78

YoY

17.67%

Last updated:

Total Debt to EBITDA Ratio of Seed Co is 2026 19.78 . Total Debt to EBITDA Ratio of Seed Co was 2025 16.81 . It decreases by 17.67% higher compared to the previous year.

The Seed Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
11.60 JPY
Jan 1, 2020
35.88 JPY
Jan 1, 2021
13.38 JPY
Jan 1, 2022
13.61 JPY
Jan 1, 2023
33.16 JPY
Jan 1, 2024
10.54 JPY
Jan 1, 2025
16.81 JPY
Jan 1, 2026
19.78 JPY
The Seed Co Debt/EBITDA history
YEARDebt/EBITDAYoY
19.78+17.67%
16.81+59.52%
10.54-68.22%
33.16+143.72%
13.61+1.70%
13.38-62.71%
35.88+209.39%
11.60+34.60%
8.62-11.75%
9.76-22.09%
12.53-45.54%
23.01+178.67%
8.26—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seed Co Stock analysis

What does Seed Co do? Seed Co., Ltd. generates revenue through its Contact Lens and Care Products segment, which offers hard, soft, and disposable contact lenses alongside lens care solutions including preservation, cleansing, enzyme cleaning, disinfectant solutions, and lens cases. The Glasses segment contributes by selling eyeglass frames and fixtures. The company also engages in intraocular lens production as part of its broader business. Revenue streams are derived from direct sales of these products to consumers and healthcare providers within the eye care market. The Contact Lens and Care Products segment targets consumers seeking daily or extended-wear contact lenses and related maintenance products. The Glasses segment serves customers purchasing eyewear frames and accessories. Intraocular lenses are likely sold to medical professionals for surgical procedures. Product categories include disposable lenses, care solutions, frames, and surgical lenses, each appealing to distinct market segments. Seed Co., Ltd. focuses on manufacturing and selling contact lenses, lens care, eyeglasses, and intraocular lenses. Its primary revenue comes from contact lens sales, particularly disposable options, and care product bundles. The Glasses segment provides complementary revenue through frame and fixture sales. Intraocular lenses represent a specialized revenue stream within the medical device sector, targeting ophthalmic surgeons and clinics. Seed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Seed Co stock

Total Debt to EBITDA Ratio of Seed Co is 19.78 in 2026.

Total Debt to EBITDA Ratio of Seed Co changed from 16.81 to 19.78, representing a 17.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Seed Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Seed Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Seed Co

All Key Metrics — Seed Co